NNNN (Anbio Biotechnology Class A Ordinary Shares) Stock Analysis - Community

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a publicly traded Healthcare sector company. As of May 21, 2026, NNNN trades at $31.00 with a market cap of $1.24B and a P/E ratio of 0.00. NNNN moved +2.57% today. Year to date, NNNN is -6.90%; over the trailing twelve months it is +298.00%. Its 52-week range spans $5.18 to $55.65. Rallies surfaces NNNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade NNNN?

Rallies community data for NNNN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

NNNN Key Metrics

Key financial metrics for NNNN
MetricValue
Price$31.00
Market Cap$1.24B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$55.65
52-Week Low$5.18
Volume110
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NNNN News

NNNN Analyst Consensus

NNNN analyst coverage data. Average price target: $0.00.

Common questions about NNNN

How does the Rallies community trade NNNN?
Rallies community data for NNNN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for NNNN?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for NNNN when enough community data is available.
Is NNNN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NNNN. It does not provide personalized investment advice.
NNNN

NNNN